1. Home
  2. GEG vs OKYO Comparison

GEG vs OKYO Comparison

Compare GEG & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEG
  • OKYO
  • Stock Information
  • Founded
  • GEG 1994
  • OKYO 2007
  • Country
  • GEG United States
  • OKYO United Kingdom
  • Employees
  • GEG N/A
  • OKYO N/A
  • Industry
  • GEG Computer Software: Prepackaged Software
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GEG Technology
  • OKYO Health Care
  • Exchange
  • GEG Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • GEG 72.4M
  • OKYO 79.7M
  • IPO Year
  • GEG N/A
  • OKYO 2022
  • Fundamental
  • Price
  • GEG $2.54
  • OKYO $1.99
  • Analyst Decision
  • GEG
  • OKYO Strong Buy
  • Analyst Count
  • GEG 0
  • OKYO 1
  • Target Price
  • GEG N/A
  • OKYO $7.00
  • AVG Volume (30 Days)
  • GEG 18.4K
  • OKYO 123.9K
  • Earning Date
  • GEG 11-12-2025
  • OKYO 07-18-2025
  • Dividend Yield
  • GEG N/A
  • OKYO N/A
  • EPS Growth
  • GEG N/A
  • OKYO N/A
  • EPS
  • GEG 0.12
  • OKYO N/A
  • Revenue
  • GEG $23,112,000.00
  • OKYO N/A
  • Revenue This Year
  • GEG N/A
  • OKYO N/A
  • Revenue Next Year
  • GEG N/A
  • OKYO N/A
  • P/E Ratio
  • GEG $22.11
  • OKYO N/A
  • Revenue Growth
  • GEG 24.82
  • OKYO N/A
  • 52 Week Low
  • GEG $1.75
  • OKYO $0.90
  • 52 Week High
  • GEG $3.51
  • OKYO $3.35
  • Technical
  • Relative Strength Index (RSI)
  • GEG 63.77
  • OKYO 39.72
  • Support Level
  • GEG $2.45
  • OKYO $1.90
  • Resistance Level
  • GEG $2.54
  • OKYO $2.54
  • Average True Range (ATR)
  • GEG 0.09
  • OKYO 0.25
  • MACD
  • GEG 0.02
  • OKYO -0.06
  • Stochastic Oscillator
  • GEG 100.00
  • OKYO 6.83

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: